NCT00233909View on ClinicalTrials.gov

A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Leukemia, Myeloid
Interventions
DRUG

Zosuquidar

DRUG

gemtuzumab ozogamicin

Sponsors
All Listed Sponsors
lead

Kanisa Pharmaceuticals

INDUSTRY

NCT00233909 - A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter